Zy Therapeutics
PrivateLast Round
Corporate Funding
Feb 2, 2020
Est. Valuation
$10M
Total Funding Raised
$9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Zy Therapeutics is a biotechnology company developing ZY-001, a therapy to directly target brain calcifications for rare central nervous system (CNS) disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zy Therapeutics Comparables
Compare Zy Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QurCan Therapeutics | 86% | |
| Optimeos Life Sciences | 85% | |
| Xanadu Bio | 76% |
Zy Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Feb 2, 2020 | ||||
| Strategic | Sep 19, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 179% MoM.
- Aug 22, 2026
Monthly visitors grew 124% MoM.
Zy Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Zy Therapeutics's valuation, stock price, and market status.
Is Zy Therapeutics a public or private company?
Zy Therapeutics is a private company.
What is the current stock price of Zy Therapeutics?
Zy Therapeutics is a private company, so its shares have no public market price. Caplight tracks Zy Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zy Therapeutics worth (valuation)?
Zy Therapeutics's valuation is estimated at $10.0M based on funding round data.
Can I buy Zy Therapeutics stock?
Zy Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zy Therapeutics's last funding round?
Zy Therapeutics's most recent funding round was Corporate Funding on February 2, 2020.
Who are the main investors in Zy Therapeutics?
Investor information for Zy Therapeutics is not publicly disclosed.
Will Zy Therapeutics IPO soon?
No public IPO plans have been announced for Zy Therapeutics.
How can I track Zy Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Zy Therapeutics's shares on secondary markets.